Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.
The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.
Corporate Stock Transfer Inc. is acting as exchange agent for the split.